FORW.PHARMA ADR/14

Depository Receipt · US34986J2042 · FWP · A2PV5H (XNCM)

No Price

n/a

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-	-	-	-	-2,07 %	1,66 %	-67,56 %

Company Profile for FORW.PHARMA ADR/14 Depository Receipt

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Company Data

Name FORW.PHARMA ADR/14

Company Forward Pharma A/S

Symbol FWP

Website https://www.forward-pharma.com

Primary Exchange

NASDAQ CAPITAL MARKET

WKN A2PV5H

ISIN US34986J2042

Asset Class Depository Receipt

Sector Healthcare

Industry Biotechnology

CEO Mr. Claus Svendsen

Country Denmark

Currency EUR

Employees 0,0 T

Address Oestergade 24A, 1, Copenhagen K, 1100 KOEBENHAVN K

IPO Date 2014-10-15

Ticker Symbols

Name	Symbol
NASDAQ	FWP

More Shares

Investors who FORW.PHARMA ADR/14 hold also have the following shares in their portfolio:

ALIGN TECHNOLOGIESLOGY INC Share

AMGEN INC Share

APPLE INC Share

AUTODESK INC Share

BULGARIEN 15/22 MTN Bond

CADENCE DESIGN SYSTEMS INC Share

CISCO SYSTEMS INC Share

COSTCO WHOLESALE CORP Share

DWS INVEST SHORT DURATION CREDIT LC Fund

INTEL CORP Share

INTRACO .NAM. Share

MICROSOFT CORP Share

SIGMA FINANCE CORPORATION (DO NOT PROCESS LINE REMOVALS / REDEMPTIONS) FLTG RTE CAPITAL NTS 16/06/14 Bond

WALGREENS BOOTS ALLIANCE INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog